TWiPO #97: GD2-CAR T Cell Therapy for H3K27M-mutated Diffuse Midline Gliomas with Dr. Robbie Majzner
Play • 26 min


Listen in as our host, Dr. Brenda Weigel from the University of Minnesota, is joined by Dr. Robbie Majzner - an Assistant Professor of Pediatrics in the Division of Hematology and Oncology at Stanford University's School of Medicine. Dr. Majzner goes into great detail about his recent clinical trial on GD2-CAR T cell therapy for H3K27M-mutated Diffuse Midline Gliomas - the findings, the process, and what the future holds. You can read more about Dr. Majzner's study here:

Have any thoughts? Questions? Ideas for future topics? Email us at

Subscribe to TWIPO to get notifications of new uploads.

Want to listen to TWIPO's past episodes? Visit

More episodes
Clear search
Close search
Google apps
Main menu